{"entity":{"id":"nct07831330","kind":"trial","name":"Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting.","summary":"Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT07831330 by The First Affiliated Hospital with Nanjing Medical University, with a registry enrolment figure of 59 participants, started 2026-09-05 and due to reach its primary completion in 2029-01-31. Interventions recorded: Albumin-bound Paclitaxel (II) + Gemcitabine. Conditions listed: Metastatic Pancreatic Adenocarcinoma; Albumin-bound Paclitaxel (II); Gemcitabine; First-Line. Primary outcome: Objective Response Rate(ORR). Pancreatic eligibility wording from the registry: \"Histopathologically or cytologically confirmed metastatic pancreatic adenocarcinoma ; 3\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07831330","url":"https://clinicaltrials.gov/study/NCT07831330"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["nab-paclitaxel","gemcitabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07831330","phase":"2","setting":"Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer: A Multicenter, Single-Arm Study","sponsor":"The First Affiliated Hospital with Nanjing Medical University","enrolled":59,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07831330/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"gemcitabine","kind":"drug","name":"Gemcitabine","route":"/drugs/gemcitabine/"},{"id":"nab-paclitaxel","kind":"drug","name":"Nab-paclitaxel","route":"/drugs/nab-paclitaxel/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}